Intravitreal bevacizumab in a patient with neovascular glaucoma

Malik Y. Kahook; Joel S. Schuman; Robert J. Noecker

doi:10.3928/1542-8877-20060301-11

Intravitreal bevacizumab in a patient with neovascular glaucoma

Malik Y. Kahook, Joel S. Schuman, Robert J. Noecker

Biomedical Engineering

Research output: Contribution to journal › Article › peer-review

Abstract

The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.

Original language	English (US)
Pages (from-to)	144-146
Number of pages	3
Journal	Ophthalmic Surgery Lasers and Imaging
Volume	37
Issue number	2
DOIs	https://doi.org/10.3928/1542-8877-20060301-11
State	Published - 2006

ASJC Scopus subject areas

Surgery
Ophthalmology

Access to Document

10.3928/1542-8877-20060301-11

Cite this

@article{f00edd999234471bb1fa41543c9def62,

title = "Intravitreal bevacizumab in a patient with neovascular glaucoma",

abstract = "The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.",

author = "Kahook, {Malik Y.} and Schuman, {Joel S.} and Noecker, {Robert J.}",

year = "2006",

doi = "10.3928/1542-8877-20060301-11",

language = "English (US)",

volume = "37",

pages = "144--146",

journal = "Ophthalmic Surgery Lasers and Imaging",

issn = "1542-8877",

publisher = "Slack Incorporated",

number = "2",

}

TY - JOUR

T1 - Intravitreal bevacizumab in a patient with neovascular glaucoma

AU - Kahook, Malik Y.

AU - Schuman, Joel S.

AU - Noecker, Robert J.

PY - 2006

Y1 - 2006

N2 - The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.

AB - The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.

UR - http://www.scopus.com/inward/record.url?scp=33645529490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645529490&partnerID=8YFLogxK

U2 - 10.3928/1542-8877-20060301-11

DO - 10.3928/1542-8877-20060301-11

M3 - Article

C2 - 16583637

AN - SCOPUS:33645529490

SN - 1542-8877

VL - 37

SP - 144

EP - 146

JO - Ophthalmic Surgery Lasers and Imaging

JF - Ophthalmic Surgery Lasers and Imaging

IS - 2

ER -

Intravitreal bevacizumab in a patient with neovascular glaucoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this